| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.47B | +11.9% |
| Cost of Revenue | $1.05B | +5.8% |
| Gross Profit | $425.9M | +30.0% |
| R&D Expense | $69.1M | +2.4% |
| SG&A Expense | $354.7M | +14.4% |
| Operating Income | $2.1M | +104.2% |
| Interest Expense | $9.3M | -29.2% |
| Pre-tax Income | -$12.1M | +80.3% |
| Income Tax | $2.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $233.9M | +7.0% |
| Inventory | $303.3M | +16.7% |
| Current Assets | $665.5M | +6.7% |
| Total Assets | $1.25B | +1.5% |
| Current Liabilities | $430.9M | +8.7% |
| Long-term Debt | $121.3M | -30.1% |
| Total Liabilities | $608.0M | -1.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $50.1M | +39.7% |
| Capital Expenditures | $15.4M | +56.1% |
| Investing Cash Flow | -$15.4M | +70.8% |
| Financing Cash Flow | -$48.9M | +3.6% |
| Free Cash Flow | $34.7M | +33.5% |
| -87.0% |
| Net Income | -$16.2M | +81.0% |
| EPS (Basic) | -$0.12 | +87.4% |
| EPS (Diluted) | -$0.12 | +87.4% |
| Stockholders' Equity |
| $633.6M |
| +4.8% |